Ma J, Brooks C, Tasoulas J, Wind LS, et al. Revisiting the use of capecitabine in the era of immunotherapy: Efficacy as second-line and later therapy in recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncol 2025;164:107293.
PMID: 40215829